Tianzhen He

State Key Laboratory Of Quality Research In Chinese Medicine
Sar, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Decoding TNF receptor superfamily control of CD4+Foxp3+ Regulatory T cell-mediated tolerance: implications for the treatment of graft‑versus‑host disease.

Decoding TNF receptor superfamily control of CD4+Foxp3+ Regulatory T cell-mediated tolerance: implications for the treatment of graft‑versus‑host disease.

Journal: Cell communication and signaling : CCS

Published: February 03, 2026

Oxymatrine inhibited the progression of renal cell carcinoma by increasing TOR1AIP1 expression.

Oxymatrine inhibited the progression of renal cell carcinoma by increasing TOR1AIP1 expression.

Journal: Frontiers in pharmacology

Published: April 13, 2025

Fused in Sarcoma (FUS) promotes renal cell carcinoma progression via the KCMF1/FUS/CENPT axis and activation of the JNK signaling pathway.

Fused in Sarcoma (FUS) promotes renal cell carcinoma progression via the KCMF1/FUS/CENPT axis and activation of the JNK signaling pathway.

Journal: Journal of translational medicine

Published: April 06, 2025

ALOXE3 expression predicts poor prognosis and modulates immune infiltration in colon adenocarcinoma.

ALOXE3 expression predicts poor prognosis and modulates immune infiltration in colon adenocarcinoma.

Journal: World journal of surgical oncology

Published: February 27, 2025

TRIP13 promotes the expansion and immunosuppression of CD4+Foxp3+ regulatory T cells by sustaining HAT1 stability.

TRIP13 promotes the expansion and immunosuppression of CD4+Foxp3+ regulatory T cells by sustaining HAT1 stability.

Journal: Cell death & disease

Published: February 04, 2025

Blocking the IL‑6 pathway to treat immune checkpoint inhibitor‑induced inflammatory arthritis (Review).

Blocking the IL‑6 pathway to treat immune checkpoint inhibitor‑induced inflammatory arthritis (Review).

Journal: Molecular medicine reports

Published: February 03, 2025

TOR1 AIP1 interacts with p53 to enhance cell cycle dysregulation in prostate cancer progression.

TOR1 AIP1 interacts with p53 to enhance cell cycle dysregulation in prostate cancer progression.

Journal: Molecular and cellular biochemistry

Published: November 05, 2024

Anti-tumor necrosis factor therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells.

Anti-tumor necrosis factor therapy in the treatment of systemic autoinflammatory diseases: the responses of innate immune cells.

Journal: Journal of leukocyte biology

Published: October 17, 2024

CENPT prevents renal cell carcinoma against ferroptosis by enhancing the synthesis of glutathione.

CENPT prevents renal cell carcinoma against ferroptosis by enhancing the synthesis of glutathione.

Journal: Cell death & disease

Published: August 30, 2024

CISD3 is a prognostic biomarker and therapeutic target in pan-cancer.

CISD3 is a prognostic biomarker and therapeutic target in pan-cancer.

Journal: Scientific reports

Published: June 04, 2024

Study on the mechanism of BGN in progression and metastasis of ccRCC.

Study on the mechanism of BGN in progression and metastasis of ccRCC.

Journal: BMC medical genomics

Published: March 24, 2024

Targeting the adenosine signaling pathway in macrophages for cancer immunotherapy.

Targeting the adenosine signaling pathway in macrophages for cancer immunotherapy.

Journal: Human immunology

Published: October 18, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026